Literature DB >> 2356159

1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): clustering of the aromatic rings in dimethylsulfoxide.

J M Matsoukas1, G Bigam, N Zhou, G J Moore.   

Abstract

The conformational properties of the octapeptide [Sar1]ANG II in dimethylsulfoxide-d6 were investigated by rotating frame nuclear Overhauser effect spectroscopy (ROESY). Interresidue ROESY interactions were observed between Tyr ortho and Phe ring protons, between Phe ring and Pro C gamma protons, and also between His C alpha and Pro C delta protons. A weak connectivity was also observed between the Sar N-CH3 protons and a Tyr ortho proton. Intraresidue interactions between alpha and beta protons in Tyr, His and Phe indicated restricted rotation for the side-chains of the three aromatic residues. These findings suggest that [Sar1]ANG II takes up a folded conformation in DMSO in which the three aromatic rings form a cluster. Connectivities between the His C alpha proton and the two Pro C delta protons illustrated a preferred conformation for angiotensin II in DMSO in which the His-Pro bond exists as the trans isomer. The NMR spectroscopic evidence is consistent with the presence of a Tyr charge relay system in the biologically active conformation of angiotensin II and with the postulated role of the Tyr hydroxyl group in angiotensin II for receptor activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2356159     DOI: 10.1016/0196-9781(90)90093-k

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.

Authors:  Gerry T M Wagenaar; El Houari Laghmani; Melissa Fidder; Rozemarijn M A Sengers; Yvonne P de Visser; Louwe de Vries; Rick Rink; Anton J M Roks; Gert Folkerts; Frans J Walther
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-06-28       Impact factor: 5.464

2.  Proton NMR studies of angiotensin II and its analogs in aqueous solution.

Authors:  N Zhou; G J Moore; H J Vogel
Journal:  J Protein Chem       Date:  1991-06

Review 3.  From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.

Authors:  John Matsoukas; Vasso Apostolopoulos; Anthony Zulli; Graham Moore; Konstantinos Kelaidonis; Kalliopi Moschovou; Thomas Mavromoustakos
Journal:  Molecules       Date:  2021-01-25       Impact factor: 4.411

4.  Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2.

Authors:  Harry Ridgway; Graham J Moore; Thomas Mavromoustakos; Sotirios Tsiodras; Irene Ligielli; Konstantinos Kelaidonis; Christos T Chasapis; Laura Kate Gadanec; Anthony Zulli; Vasso Apostolopoulos; Russell Petty; Ioannis Karakasiliotis; Vassilis G Gorgoulis; John M Matsoukas
Journal:  Comput Struct Biotechnol J       Date:  2022-04-09       Impact factor: 6.155

5.  Actions of Novel Angiotensin Receptor Blocking Drugs, Bisartans, Relevant for COVID-19 Therapy: Biased Agonism at Angiotensin Receptors and the Beneficial Effects of Neprilysin in the Renin Angiotensin System.

Authors:  Graham J Moore; Harry Ridgway; Konstantinos Kelaidonis; Christos T Chasapis; Irene Ligielli; Thomas Mavromoustakos; Joanna Bojarska; John M Matsoukas
Journal:  Molecules       Date:  2022-07-29       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.